Status:
COMPLETED
A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor
Lead Sponsor:
Montefiore Medical Center
Collaborating Sponsors:
Abbott
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
Pharmacologic boosting of protease inhibitors with ritonavir has become standard practice in antiretroviral therapy. Patients are instructed to take ritonavir at the same time as its accompanying prot...
Detailed Description
The study staff will employ MEMS caps to prospectively measure adherence to ritonavir and its accompanying protease inhibitor over 24 weeks of follow-up. Paired sample t-tests will be employed to comp...
Eligibility Criteria
Inclusion
- HIV infection, age\>18 years, receiving therapy with ritonavir-boosted atazanavir or fosamprenavir, willingness to use MEMS caps, willingness to provide informed consent
Exclusion
- Treatment with any medication that is contraindicated in combination with ritonavir or its accompanying protease inhibitor
Key Trial Info
Start Date :
June 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2007
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00432783
Start Date
June 1 2006
End Date
August 1 2007
Last Update
April 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467